Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2012
02/29/2012CN101229098B Method for preparation of microsphere and apparatus therefor
02/29/2012CN101204421B Traditional Chinese traditional medicine composition for dispelling wind, activating blood circulation, stopping pain and preparation method thereof
02/29/2012CN101152396B Wuzishenqi nourishing honey bolus and technique of preparing the same
02/29/2012CN101010065B Silicone adhesive formulation containing an antiperspirant
02/29/2012CN101007056B An antitumor medicinal composition and its preparation method
02/28/2012US8124795 Process for modifying drug crystal formation
02/28/2012US8124689 Silicone acrylate hybride composition and method of making same
02/28/2012US8124687 Random ethylene oxide copolymer and non-random alkylene oxide(s) polymer with bioactive agent
02/28/2012US8124654 Derivatives of hypoestoxide and related compounds
02/28/2012US8124608 Mixture of disaccharides, polysaccharides and solvent
02/28/2012US8124590 Biodegradable immunomodulatory formulations and methods for use thereof
02/28/2012US8124587 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa
02/28/2012US8124586 Prevention and reduction of blood loss
02/28/2012US8124141 Rapidly absorbing lipophilic skin compositions and uses therefor
02/28/2012US8124129 Crystalline form of the compound A-348441
02/28/2012US8124128 For delivery of water insoluble drugs, growth factors, genes, or cosmetic substances; biocompatible and biodegradable
02/28/2012US8124127 Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
02/28/2012US8124126 Pharmaceutical compositions
02/28/2012US8124125 Solid dosage form comprising a fibrate
02/28/2012US8124124 Compressed tablet containing non-steroid antiinflammatory drug
02/28/2012US8124123 Controlled release azithromycin solid dosages forms
02/28/2012US8124122 Female hormone-containing patch
02/28/2012US8124121 Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
02/28/2012US8124120 Preparing and using crosslinked, water insoluble, hydrated hyaluronic acid gel particles; in vivo biostability and mechanical properties, usability; ease of injection through fine needles
02/28/2012US8124118 Composition comprising biodegradable hydrating ceramics for controlled drug delivery
02/28/2012US8124072 sufficient quantity of limonene suitable to solubilize said coenzyme Q-10 and carnitine; and an acceptable carrier
02/28/2012US8124057 Propellant-based nanoparticulate dry powder aerosols and method of making
02/28/2012US8123849 Aqueous film coating composition containing sodium alginate and preparation thereof
02/28/2012US8123716 Pericardial delivery of treatment
02/28/2012US8123509 Injection molding process for the preparation of an oral delivery device for the pharmaceutically active agent
02/28/2012US8122849 Apparatus and method for producing a pharmaceutical product
02/28/2012CA2514019C Topical pharmaceutical and/or cosmetic dispense systems
02/28/2012CA2505139C Oromucosal formulation and process for preparing the same
02/28/2012CA2503361C Controlled-release compositions
02/28/2012CA2500215C Nucleic acid coated particles
02/28/2012CA2356881C Compositions having improved delivery of actives
02/28/2012CA2285947C Vaginal lactobacillus medicant
02/23/2012WO2012024634A2 Environmentally-responsive nanocomposites and methods of their use
02/23/2012WO2012024632A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e
02/23/2012WO2012024621A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
02/23/2012WO2012024530A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
02/23/2012WO2012024360A2 Tablet sleeve for improved performance
02/23/2012WO2012024298A1 Ophthalmic formulations of squalamine
02/23/2012WO2012024287A1 Method of stabilizing and sterilizing peptides or proteins
02/23/2012WO2012024229A1 Yeast cell wall particle for receptor-targeted nanoparticle delivery
02/23/2012WO2012024196A2 A novel method for creating, suspending and stabilizing electronically modified reaction intermideates
02/23/2012WO2012023955A1 Phospholipid depot
02/23/2012WO2012023873A1 Combination of vitamins and minerals
02/23/2012WO2012023609A1 Atomization device
02/23/2012WO2012023179A1 Long-acting dermatological antipruritic agent
02/23/2012WO2012023146A1 A pharmaceutical composition of reformulated turmeric extract and a method thereof
02/23/2012WO2012023082A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - terbinafine hydrochloride, and a process to make it
02/23/2012WO2012023081A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - hydrocortisone acetate, and an antifungal agent - oxiconazole nitrate, and a process to make it
02/23/2012WO2012023080A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - fluticasone propionate, and an antifungal agent -terbinafine hydrochloride and a process to make it
02/23/2012WO2012023078A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - dexamethasone acetate, and an antifungal agent - oxiconazole nitrate, and a process to make it
02/23/2012WO2012023077A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid - clobetasol propionate, and an antifungal agent - oxiconazole nitrate, and a process to make it
02/23/2012WO2012023024A2 Controlled release formulations of dronedarone
02/23/2012WO2012022920A1 Device that is implantable in the temporal bone for delivering a material, and hearing aid provided with such a device
02/23/2012WO2012022919A2 Nalbuphine-based formulations and uses thereof
02/23/2012WO2012022837A1 Transdermal compositions
02/23/2012WO2012022775A1 Concentrate for medical solutions, production thereof and use thereof in dialysis
02/23/2012WO2012022773A1 Probiotic composition for oral health
02/23/2012WO2012022737A1 Compositions and methods for improved organ transplant preservation and acceptance
02/23/2012WO2012022498A1 Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
02/23/2012WO2012022223A1 Composition comprising ligustroflavone, rhoifolin and hyperin, and use thereof in the preparation of a medicament
02/23/2012WO2012021922A1 Particulate substances comprising ceramic particles for delivery of biomolecules
02/23/2012WO2012003470A3 Antibody formulations
02/23/2012WO2012003045A3 Process for the preparation of poly(alkylene oxide) derivatives for modification of biologically active molecules and materials
02/23/2012WO2011151418A8 Nanosuspension formulation comprising a polydimethylsiloxane hydrophobic phase
02/23/2012WO2011143526A9 Topical peripheral neuro-affective (tpna) therapy
02/23/2012WO2011143347A3 Film coating composition and methods of making and using the same
02/23/2012WO2011134679A3 Selected plant extracts for the treatment of inflammatory diseases
02/23/2012WO2011133463A3 Antimicrobial compositions comprising organic acid esters and methods for reducing virus and bacterial populations using such compositions
02/23/2012WO2011131765A3 Artificial tear emulsion
02/23/2012WO2011130707A3 Compounds, compositions, and methods for reducing or eliminating bitter taste
02/23/2012WO2011130486A9 Combination treatments and formulations for cancer
02/23/2012WO2011130362A3 Easily appliable, storage stable, radiation-curable, pigmented, artificial nail gel coatings
02/23/2012WO2011127252A3 Miniature ingestible device
02/23/2012WO2011126810A3 Intravaginal drug delivery device
02/23/2012WO2011119477A3 Pharmaceutical compositions of carvedilol salts and process for preparation thereof
02/23/2012WO2011112919A3 A novel method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer
02/23/2012WO2011109367A4 Methods and compositions for treating or preventing symptoms of hormonal variations
02/23/2012WO2011093831A3 Effervescent formulations comprising cefprozil as active agent
02/23/2012WO2011093828A3 Solid dosage forms comprising cefprozil
02/23/2012WO2011093820A3 A pharmaceutical combination comprising tiotropium
02/23/2012WO2011093819A3 New pharmaceutical combination comprising tiotropium
02/23/2012WO2011093818A3 Pharmaceutical compositions comprising salmeterol and fluticasone
02/23/2012WO2011093811A3 Pharmaceutical preparations comprising formoterol and fluticasone
02/23/2012WO2011093810A3 Dry powder pharmaceutical composition comprising tiotropium and mometasone
02/23/2012WO2011093809A3 Dry powder pharmaceutical composition comprising tiotropium and ciclesonide
02/23/2012WO2011076209A3 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
02/23/2012WO2011060290A3 Immediate release tablet formulations
02/23/2012WO2011054930A3 Pharmaceutical solid dosage form
02/23/2012WO2011042463A3 Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer
02/23/2012US20120046638 Method of inducing a CTL response
02/23/2012US20120046360 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
02/23/2012US20120046310 Compositions for delivering highly water soluble drugs
02/23/2012US20120046296 Palatable ductile chewable veterinary composition
02/23/2012US20120046281 Rifalazil compositions and therapeutic regimens
02/23/2012US20120046252 Calcium Formate for Use as a Dietary Supplement
1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 2991